H1N1 Influenza A infection
... about swine influenza (pig flu) as scientists try to learn more about this emerging disease. Titles such as “a new flu pandemic” or “deadly flu” are in the first pages of most newspapers and websites. Outbreaks of this infectious new strain of influenza virus have proved deadly in some places and re ...
... about swine influenza (pig flu) as scientists try to learn more about this emerging disease. Titles such as “a new flu pandemic” or “deadly flu” are in the first pages of most newspapers and websites. Outbreaks of this infectious new strain of influenza virus have proved deadly in some places and re ...
2. - Environmental Public Health Today
... ▫ Primary drugs being oseltamivir and zanamivir; active against both type A and type B. Amantadine is no longer effective (Fauci et al, 2008) ▫ Oseltamivir can be used on patients of any age while zanamivir is approved for those aged 7 years and older. ▫ Antiviral drugs are used in severe cases, oth ...
... ▫ Primary drugs being oseltamivir and zanamivir; active against both type A and type B. Amantadine is no longer effective (Fauci et al, 2008) ▫ Oseltamivir can be used on patients of any age while zanamivir is approved for those aged 7 years and older. ▫ Antiviral drugs are used in severe cases, oth ...
Disability Development Resources, L.L.C. Pandemic Influenza
... In the U.S., complications of influenza cause an average of 36,000 deaths each year, primarily among the elderly. The influenza virus is transmitted indirectly in most cases by airborne droplets expelled from infected persons by coughing and sneezing, but it can be transmitted by direct contact. Typ ...
... In the U.S., complications of influenza cause an average of 36,000 deaths each year, primarily among the elderly. The influenza virus is transmitted indirectly in most cases by airborne droplets expelled from infected persons by coughing and sneezing, but it can be transmitted by direct contact. Typ ...
Slide 1
... • Workers who assume increased risks due to their occupation and who provide benefits broadly to society – such as healthcare workers, firefighters, emergency medical services personnel, etc. – should be protected, if possible. • Society has an obligation to provide health workers with the protectio ...
... • Workers who assume increased risks due to their occupation and who provide benefits broadly to society – such as healthcare workers, firefighters, emergency medical services personnel, etc. – should be protected, if possible. • Society has an obligation to provide health workers with the protectio ...
Reprint
... Mitigation without vaccination Nonpharmaceutical interventions considered in published models of influenza transmission include isolation of infectious cases, quarantine of potentially infectious but asymptomatic contacts, and “social distancing” measures such as school closures.7 Models suggest tha ...
... Mitigation without vaccination Nonpharmaceutical interventions considered in published models of influenza transmission include isolation of infectious cases, quarantine of potentially infectious but asymptomatic contacts, and “social distancing” measures such as school closures.7 Models suggest tha ...
Outcomes of adults hospitalised with severe influenza
... adults.15e17 Patients may present late with serious complications, which result in the requirements for oxygen/ventilatory support, intensive care, prolonged hospitalisations or even deaths.15 18e25 The lack of data may have reflected the difficulties in performing randomised placebo-controlled trials ...
... adults.15e17 Patients may present late with serious complications, which result in the requirements for oxygen/ventilatory support, intensive care, prolonged hospitalisations or even deaths.15 18e25 The lack of data may have reflected the difficulties in performing randomised placebo-controlled trials ...
H1N1 Influenza Fact Sheet
... You cannot get H1N1 flu from eating pork or pork products. Eating properly handled and cooked pork and pork products is safe. Cooking pork to an internal temperature of 160°F kills all viruses and other food-borne pathogens. How serious is H1N1 flu infection? Like seasonal flu, H1N1 flu in people ca ...
... You cannot get H1N1 flu from eating pork or pork products. Eating properly handled and cooked pork and pork products is safe. Cooking pork to an internal temperature of 160°F kills all viruses and other food-borne pathogens. How serious is H1N1 flu infection? Like seasonal flu, H1N1 flu in people ca ...
H1N1 - Sonoco
... Most people who get influenza recover completely on their own, with no treatment. Sometimes overthe-counter medicines, such as paracetamol / acetominophen, are useful to help relieve symptoms such as fever and headache. It is important to make sure that sick people - especially children drink enough ...
... Most people who get influenza recover completely on their own, with no treatment. Sometimes overthe-counter medicines, such as paracetamol / acetominophen, are useful to help relieve symptoms such as fever and headache. It is important to make sure that sick people - especially children drink enough ...
H1N1 & Seasonal Influenza: Improving Your Vaccination Program
... – HCW taking antivirals doesn’t protect your patients ...
... – HCW taking antivirals doesn’t protect your patients ...
Influenza - WordPress.com
... • Reasonably effective ways to reduce the transmission of influenza include good personal health and hygiene habits such as: not touching your eyes, nose or mouth;[102] frequent hand washing (with soap and water, or with ...
... • Reasonably effective ways to reduce the transmission of influenza include good personal health and hygiene habits such as: not touching your eyes, nose or mouth;[102] frequent hand washing (with soap and water, or with ...
UNC Management of H1N1
... • http://alertcarolina.unc.edu/go/site/1395/ • http://ehs.unc.edu/ • http://campushealth.unc.edu/ ...
... • http://alertcarolina.unc.edu/go/site/1395/ • http://ehs.unc.edu/ • http://campushealth.unc.edu/ ...
Fact sheet - Seasonal/Avian/Pandemic influenza
... immunity. It is impossible to predict where and when an influenza pandemic might begin. There are steps in place to prevent pandemic influenza from occurring in Australia. In the event of an influenza pandemic, good respiratory hygiene habits that reduce the spread of seasonal influenza will also re ...
... immunity. It is impossible to predict where and when an influenza pandemic might begin. There are steps in place to prevent pandemic influenza from occurring in Australia. In the event of an influenza pandemic, good respiratory hygiene habits that reduce the spread of seasonal influenza will also re ...
influenza (flu)
... B. VACCINATION: • Two types are available: – Attenuated (nasal spray): • Contains weakened but live virus. • May cause the flu in those with weakened immune system. ...
... B. VACCINATION: • Two types are available: – Attenuated (nasal spray): • Contains weakened but live virus. • May cause the flu in those with weakened immune system. ...
(Antiviral) Drugs
... and even then the availability of doses will be staggered and limited. Furthermore, each individual may need to receive two doses of vaccine to be protected. At this time antivirals (anti-influenza drugs) are the only specific medical intervention that targets influenza and that potentially will be ...
... and even then the availability of doses will be staggered and limited. Furthermore, each individual may need to receive two doses of vaccine to be protected. At this time antivirals (anti-influenza drugs) are the only specific medical intervention that targets influenza and that potentially will be ...
PDF - International Journal of Drug Development and Research
... was increased from 0% to 20%, the Flag decreased, and this effect was significant on reducing Flag up to 10% of EC and beyond that there is no significant decrease in Flag. Hence, it was decided to optimize the amount of EC between 0% and 10%. As the amount ...
... was increased from 0% to 20%, the Flag decreased, and this effect was significant on reducing Flag up to 10% of EC and beyond that there is no significant decrease in Flag. Hence, it was decided to optimize the amount of EC between 0% and 10%. As the amount ...
Epidemiological, Demographic, and Molecular Characteristics of
... the 514 year age group, without any gender predominance. The analyzed strains had À98.9z homolo gy with vaccine strains and with each other. More than 37z of the isolates had mutation at position D222E/N on HA gene. There was no isolate harbored mutation at the position H275Y of the NA gene, indic ...
... the 514 year age group, without any gender predominance. The analyzed strains had À98.9z homolo gy with vaccine strains and with each other. More than 37z of the isolates had mutation at position D222E/N on HA gene. There was no isolate harbored mutation at the position H275Y of the NA gene, indic ...
Dose-dependent antiviral activity of released
... The assessment of dose–response is an essential part of drug development in terms of the determination of a drug’s effective dose, finding the safety endpoint, estimation of the pharmacokinetic profile, and even validation of drug activity, especially for therapeutic agents with a principally novel ...
... The assessment of dose–response is an essential part of drug development in terms of the determination of a drug’s effective dose, finding the safety endpoint, estimation of the pharmacokinetic profile, and even validation of drug activity, especially for therapeutic agents with a principally novel ...
Fact Sheet
... To date, there have been no reports of avian influenza in birds or people in Australia and the Australian Government has many measures in place to prevent the emergence of avian influenza in Australia. Because the avian influenza virus has not been shown to definitely spread from person to person, i ...
... To date, there have been no reports of avian influenza in birds or people in Australia and the Australian Government has many measures in place to prevent the emergence of avian influenza in Australia. Because the avian influenza virus has not been shown to definitely spread from person to person, i ...
Antiviral Therapy and Prophylaxis for Influenza in Children
... of the most recent cases were reported from Japan, a country with approximately 4 times more courses of oseltamivir prescribed than in the United States, package labeling was changed in the United States in 2006 to alert physicians to the possibility of these rare and unusual clinical findings. Accu ...
... of the most recent cases were reported from Japan, a country with approximately 4 times more courses of oseltamivir prescribed than in the United States, package labeling was changed in the United States in 2006 to alert physicians to the possibility of these rare and unusual clinical findings. Accu ...
Creating the Future for CDC in the 21st Century
... – May begin 1 day before symptom onset – Peak viral shedding on day 1 of symptoms – Adults shed for 4-6 days – Infants and children may shed longer – Immunocompromised patients can shed for months ...
... – May begin 1 day before symptom onset – Peak viral shedding on day 1 of symptoms – Adults shed for 4-6 days – Infants and children may shed longer – Immunocompromised patients can shed for months ...
Direct Link - TUSK: Tufts
... • IV formulation of neuraminidase inhibitor • Recently FDA approved for treatment of uncomplicated influenza • Dosed as one time 600 mg dose IV • Potential adverse events include rash, elevated creatinine, CNS side effects (delirium, halllucinations, abnormal behavior) ...
... • IV formulation of neuraminidase inhibitor • Recently FDA approved for treatment of uncomplicated influenza • Dosed as one time 600 mg dose IV • Potential adverse events include rash, elevated creatinine, CNS side effects (delirium, halllucinations, abnormal behavior) ...
If Pigs Could Fly, Would They Carry Bird Flu?
... denounces WHO’s “waste of large sums of public ...
... denounces WHO’s “waste of large sums of public ...
Summary Results of Western North Carolina
... Number of Patients Seen per Week < 25 per week 25 – 50 per week 51 – 100 per week > 100 per week ...
... Number of Patients Seen per Week < 25 per week 25 – 50 per week 51 – 100 per week > 100 per week ...
Slide 1
... * household close contacts (of confirmed, probable, or suspected case) at high-risk for complications of influenza + chronic medical conditions ...
... * household close contacts (of confirmed, probable, or suspected case) at high-risk for complications of influenza + chronic medical conditions ...
Oseltamivir
Oseltamivir INN /ɒsəlˈtæmɨvɪər/, marketed under the trade name Tamiflu, is an antiviral medication used to treat influenza A and influenza B (flu), and to prevent flu after exposure. The medication is taken orally.The Infectious Disease Society of America, the United States' Centers for Disease Control and Prevention (CDC), and the United Kingdom's National Institute for Health and Care Excellence recommend the use of oseltamavir for people who have complications or are at high risk for complications who present within 48 hours of first symptoms of infection. They recommend its use to prevent infection in at-risk people but not the general population. The CDC recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. However, these recommendations are controversial as are criticisms of the recommendations. A Cochrane review concluded that oseltamivir does not reduce hospitalizations, and that there is no evidence of reduction in complications of influenza (such as pneumonia) because of a lack of diagnostic definitions, or reduction of the spread of the virus. Two meta-analyses have concluded that benefits in those who are otherwise healthy do not outweigh its risks. They also found little evidence regarding whether treatment changes the risk of hospitalization or death in high risk populations. However, another meta-analysis found that oseltamivir was effective for prevention of influenza at the individual and household levels.Side effects include psychiatric symptoms, increased rates of vomiting, and headaches. It is pregnancy category C in the United States and category B in Australia meaning that it has been taken by a small number of women without signs of problems and in animal studies it looks safe. Dose adjustment may be needed in those with kidney problems.It was the first orally administered neuraminidase inhibitor commercially developed. It was discovered and developed by US-based Gilead Sciences, which licensed the exclusive rights to Roche in 1996. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.